BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Initial Evaluation of New Nucleus Removal Device Provides Promising Results CoreSpine Technologies' Device


10/18/2007 9:47:56 AM

MINNEAPOLIS, Oct. 18 /PRNewswire/ -- CoreSpine Technologies LLC, an emerging spinal device company located in Minneapolis, Minnesota announced today the completion of the company's initial cadaver evaluations.

CoreSpine's first product in development is a complete nucleus removal device that seeks to remove the nucleus pulposus from the lumbar disc space, while not damaging the annulus or endplates. In addition, its design characteristics allow the device to be used in multiple surgical approaches, including the preferred posterior approach.

"This set of successful evaluations illustrates that the prototype has made progress towards a device that addresses the clinical needs for safe and complete nucleus resection," said John Sherman, M.D., Medical Director for CoreSpine. Dr. Sherman continued, "The device created a larger nucleus cavity than the rongeur and damage to the annulus and endplates was minimized."

"We're pleased with the data that was generated from the labs. As Dr. Sherman stated, the results of the initial work are promising and will be used to guide the near-term engineering refinements, "said Britt Norton, Co-Founder of CoreSpine Technologies. Mr. Norton continued, "CoreSpine has submitted data and information for presentation at international spine meetings in 2008."

About CoreSpine Technologies, LLC

CoreSpine Technologies is a privately held medical device company. It is focused solely on the design and development of improved nucleus removal devices, which will be a crucial step in the optimum placement of nucleus replacement and minimally invasive fusion implants. CoreSpine's first products will mechanically remove the nucleus from the lumbar disc space, while sparing annulus and endplate tissues. For additional information, please contact Christine Horton at christine@corespinetech.com or Britt Norton at britt@corespinetech.com, or visit the company's website at http://www.corespinetech.com.

CONTACT: Christine M. Horton, Founder, CoreSpine Technologies,
+1-612-759-2600, Christine@corespinetech.com

Web site: http://www.corespinetech.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES